This report was recently updated on April 28 2024 with the latest and most recent
market numbers
Global Antibody Discovery Market Size, Trends & Analysis - Forecasts to 2028 By Methods (Phage Display, Hybridoma, and Others), By Antibody Type (Humanized Antibody, Human Antibody, Chimeric Antibody, and Murine Antibody), By End User (Pharmaceutical and Biotechnology Industry, Research Laboratory, and Academic Laboratory), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global antibody discovery market is projected to grow at a CAGR of 9.9% from 2023 to 2028. The increasing occurrence of long-term illnesses like cancer and autoimmune disorders has led to a growing need for therapeutic antibodies, particularly those produced through monoclonal antibody production. As of September 2023, the World Health Organization reports that globally, cardiovascular diseases cause the most non-communicable disease (NCD) deaths, affecting 17.9 million people annually. This is followed by cancer-related deaths at 9.3 million, chronic respiratory diseases at 4.1 million, and diabetes, which includes deaths from diabetes-induced kidney disease at 2.0 million annually.
The shift towards personalized medicine has increased the demand for targeted therapies, leading to advancements in antibody engineering and design and recombinant antibody synthesis. Collaborations between pharmaceutical companies, biotechnology firms, and academic research institutions often involve antibody sequencing services, immune repertoire analysis, and single-cell sequencing for antibody discovery, which also contributes to the growth of the antibody discovery market.
As the world's population ages, age-related diseases are on the rise, emphasizing the importance of validating and characterizing antibodies. According to WHO, by 2030, 1 in 6 people worldwide will be aged 60 years or over.
However, antibody discovery and development can be an expensive and time-consuming process. The costs associated with research, preclinical and clinical trials, and manufacturing can be significant, limiting the accessibility of antibody therapies.
The phage display segment is expected to hold the largest share of the market. The dominance is attributed to the strong and adaptable nature of the phage display method. This technique excels in presenting antibody fragments on phage surfaces, facilitating the screening of a broad pool of potential candidates for specific antigens. Its adaptability across diagnostics, therapeutics, and research tools makes it a favoured method.
The hybridoma segment is expected to be the fastest-growing segment in the market from 2023-2028, owing to hybridoma technology's proven ability to produce particular monoclonal antibodies. These antibodies can target various diseases, making them useful for different therapeutic and diagnostic purposes. Even with the growing advanced technologies such as recombinant DNA techniques and phage display, the continuous success and reliable nature of hybridoma technology results in the preferred choice for scientists and pharmaceutical companies.
The murine antibody is anticipated to be the fastest-growing segment in the market from 2023-2028. The anticipated growth is due to well-established research infrastructure. Derived from mice, murine antibodies have played a pivotal role in research and therapy development for an extended period, resulting in a rich knowledge base and readily available resources. While humanized and fully human antibodies provide benefits through decreased immunogenicity, murine antibodies remain equally crucial and valuable, especially during the initial screening and research stages.
The human antibody segment is expected to hold the largest share of the market over the forecast period. The dominance of human antibodies within this market can be attributed to their distinct advantages, contributing to their extensive market presence. Human antibodies, derived from the human immune system, offer heightened safety characteristics, reduced likelihood of triggering immune responses, and increased therapeutic efficacy.
The academic laboratory segment is anticipated to be the fastest-growing segment in the market from 2023-2028. Academic institutions offer funding for research projects, a wide range of expertise, and advanced research capabilities. Their collaborative environment encourages groundbreaking discoveries and interdisciplinary research. Furthermore, academia plays a crucial role in basic research, identifying targets, and developing early-stage antibodies, which can result in new therapeutic options.
The pharmaceutical and biotechnology industry segment is expected to hold the largest share of the market. This significant dominance is attributed to the industry players’ substantial investments in research and development, well-established infrastructure, and expertise in drug development. Their capacity to bring antibody-based drugs to market positions them as key players, contributing to their significant share in the antibody discovery sector.
North America is expected to be the largest region in the market. The primary reasons boosting the market growth in this region include increasing cancer-related cases. For instance, in 2020, the American Cancer Society documented around 1.8 million new cancer cases and 606,520 deaths related to cancer in the U.S., highlighting the need for therapeutic antibodies and contributing to the expansion of the market. The increased funding has also empowered scientists to undertake large-scale clinical trials essential for evaluating the efficacy of specific antibodies.
Asia Pacific is predicted to witness rapid growth during the forecast period. The growth is due to an increase in chronic illnesses and the incidence of cardiovascular diseases. For instance, according to the Journal of Biomedical and Environmental Science, in 2021, around 330 million individuals in China were affected by cardiovascular diseases. Additionally, market players' collaborative efforts contribute to the accelerated pace of antibody drug discovery in Asia Pacific. For instance, in December 2022, the partnership between GenScript Biotech Corporation (U.S.) and Allozymes (Singapore) significantly enhanced the allozyme antibody production platform. These factors drive the market growth in the region.
Danaher Corporation, Evotec, Biocytogen, Genscript Technology Corporation, Eurofins Scientific, Creative Biolabs, Charles River Laboratories, Sartorius AG, Twist Bioscience, and Fairjourney Biologics S.A, among others, are some of the key players operating in the global antibody discovery market.
Please note: This is not an exhaustive list of companies profiled in the report.
In March 2023, Biocytogen Pharmaceuticals entered into a non-exclusive license agreement with Janssen Biotech, granting Janssen access to Biocytogen's RenLite platform for global research, development, and commercialization of fully human antibody therapeutics. RenLite enables the efficient generation of high-quality antibodies with a common light chain, enhancing the production of bispecific and multispecific antibodies for diverse drug targets and indications.
In August 2023, Danaher Corporation, a science and technology innovator company, announced the acquisition of Abcam plc, a provider of protein consumables. This strategic move aligns with Danaher's commitment to addressing significant healthcare challenges and leveraging Abcam's innovation and expertise in the life sciences research community.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL ANTIBODY DISCOVERY MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL ANTIBODY DISCOVERY MARKET, BY METHODS
4.1 Introduction
4.2 Antibody Discovery Market: Methods Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4 Phage Display
4.4.1 Phage Display Market Estimates and Forecast, 2020-2028 (USD Million)
4.5 Hybridoma
4.5.1 Hybridoma Market Estimates and Forecast, 2020-2028 (USD Million)
4.6 Others
4.6.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
5 GLOBAL ANTIBODY DISCOVERY MARKET, BY END USER
5.1 Introduction
5.2 Antibody Discovery Market: End User Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4 Pharmaceutical and Biotechnology Industry
5.4.1 Pharmaceutical and Biotechnology Industry Market Estimates and Forecast, 2020-2028 (USD Million)
5.5 Research Laboratory
5.5.1 Research Laboratory Market Estimates and Forecast, 2020-2028 (USD Million)
5.6 Academic Laboratory
5.6.1 Academic Laboratory Market Estimates and Forecast, 2020-2028 (USD Million)
6 GLOBAL ANTIBODY DISCOVERY MARKET, BY ANTIBODY TYPE
6.1 Introduction
6.2 Antibody Discovery Market: Antibody Type Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4 Humanized Antibody
6.4.1 Humanized Antibody Market Estimates and Forecast, 2020-2028 (USD Million)
6.5 Human Antibody
6.5.1 Human Antibody Market Estimates and Forecast, 2020-2028 (USD Million)
6.6 Murine Antibody
6.6.1 Murine Antibody Market Estimates and Forecast, 2020-2028 (USD Million)
6.7 Chimeric Antibody
6.7.1 Chimeric Antibody Market Estimates and Forecast, 2020-2028 (USD Million)
7 GLOBAL ANTIBODY DISCOVERY MARKET, BY REGION
7.1 Introduction
7.2 North America Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.2.1 By Methods
7.2.2 By End User
7.2.3 By Antibody Type
7.2.4 By Country
7.2.4.1 U.S. Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.1.1 By Methods
7.2.4.1.2 By End User
7.2.4.1.3 By Antibody Type
7.2.4.2 Canada Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.2.1 By Methods
7.2.4.2.2 By End User
7.2.4.2.3 By Antibody Type
7.2.4.3 Mexico Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.2.4.3.1 By Methods
7.2.4.3.2 By End User
7.2.4.3.3 By Antibody Type
7.3 Europe Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.1 By Methods
7.3.2 By End User
7.3.3 By Antibody Type
7.3.4 By Country
7.3.4.1 Germany Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.1.1 By Methods
7.3.4.1.2 By End User
7.3.4.1.3 By Antibody Type
7.3.4.2 U.K. Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.2.1 By Methods
7.3.4.2.2 By End User
7.3.4.2.3 By Antibody Type
7.3.4.3 France Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.3.1 By Methods
7.3.4.3.2 By End User
7.3.4.3.3 By Antibody Type
7.3.4.4 Italy Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.4.1 By Methods
7.3.4.4.2 By End User
7.2.4.4.3 By Antibody Type
7.3.4.5 Spain Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.5.1 By Methods
7.3.4.5.2 By End User
7.2.4.5.3 By Antibody Type
7.3.4.6 Netherlands Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.6.1 By Methods
7.3.4.6.2 By End User
7.2.4.6.3 By Antibody Type
7.3.4.7 Rest of Europe Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.3.4.7.1 By Methods
7.3.4.7.2 By End User
7.2.4.7.3 By Antibody Type
7.4 Asia Pacific Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.1 By Methods
7.4.2 By End User
7.4.3 By Antibody Type
7.4.4 By Country
7.4.4.1 China Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.1.1 By Methods
7.4.4.1.2 By End User
7.4.4.1.3 By Antibody Type
7.4.4.2 Japan Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.2.1 By Methods
7.4.4.2.2 By End User
7.4.4.2.3 By Antibody Type
7.4.4.3 India Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.3.1 By Methods
7.4.4.3.2 By End User
7.4.4.3.3 By Antibody Type
7.4.4.4 South Korea Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.4.1 By Methods
7.4.4.4.2 By End User
7.4.4.4.3 By Antibody Type
7.4.4.5 Singapore Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.5.1 By Methods
7.4.4.5.2 By End User
7.4.4.5.3 By Antibody Type
7.4.4.6 Malaysia Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.6.1 By Methods
7.4.4.6.2 By End User
7.4.4.6.3 By Antibody Type
7.4.4.7 Thailand Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.7.1 By Methods
7.4.4.7.2 By End User
7.4.4.7.3 By Antibody Type
7.4.4.8 Indonesia Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.8.1 By Methods
7.4.4.8.2 By End User
7.4.4.8.3 By Antibody Type
7.4.4.9 Vietnam Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.9.1 By Methods
7.4.4.9.2 By End User
7.4.4.9.3 By Antibody Type
7.4.4.10 Taiwan Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.10.1 By Methods
7.4.4.10.2 By End User
7.4.4.10.3 By Antibody Type
7.4.4.11 Rest of Asia Pacific Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.4.4.11.1 By Methods
7.4.4.11.2 By End User
7.4.4.11.3 By Antibody Type
7.5 Middle East and Africa Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.1 By Methods
7.5.2 By End User
7.5.3 By Antibody Type
7.5.4 By Country
7.5.4.1 Saudi Arabia Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.1.1 By Methods
7.5.4.1.2 By End User
7.5.4.1.3 By Antibody Type
7.5.4.2 U.A.E. Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.2.1 By Methods
7.5.4.2.2 By End User
7.5.4.2.3 By Antibody Type
7.5.4.3 Israel Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.3.1 By Methods
7.5.4.3.2 By End User
7.5.4.3.3 By Antibody Type
7.5.4.4 South Africa Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.4.1 By Methods
7.5.4.4.2 By End User
7.5.4.4.3 By Antibody Type
7.5.4.5 Rest of Middle East and Africa Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.4.5.1 By Methods
7.5.4.5.2 By End User
7.5.4.5.2 By Antibody Type
7.6 Central and South America Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.1 By Methods
7.6.2 By End User
7.6.3 By Antibody Type
7.6.4 By Country
7.6.4.1 Brazil Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.1.1 By Methods
7.6.4.1.2 By End User
7.6.4.1.3 By Antibody Type
7.6.4.2 Argentina Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.2.1 By Methods
7.6.4.2.2 By End User
7.6.4.2.3 By Antibody Type
7.6.4.3 Chile Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.3.1 By Methods
7.6.4.3.2 By End User
7.6.4.3.3 By Antibody Type
7.6.4.4 Rest of Central and South America Antibody Discovery Market Estimates and Forecast, 2020-2028 (USD Million)
7.6.4.4.1 By Methods
7.6.4.4.2 By End User
7.6.4.4.3 By Antibody Type
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Rest of the World
8.4 Company Profiles
8.4.1 Biocytogen
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 Twist Bioscience
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 Creative Biolabs
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 Genscript Technology Corporation
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Eurofins Scientific.
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 Sartorius AG
8.4.6.1 Business Description & Financial Analysis
8.4.6.2 SWOT Analysis
8.4.6.3 Products & Services Offered
8.4.6.4 Strategic Alliances between Business Partners
8.4.7 Fairjourney Biologics S.A
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 Danaher Corporation
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 Evotec
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 Charles River Laboratories
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH METHODOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
LIST OF TABLES
1 Global Antibody Discovery Market, By Methods, 2020-2028 (USD Mllion)
2 Phage Display Market, By Region, 2020-2028 (USD Mllion)
3 Hybridoma Market, By Region, 2020-2028 (USD Mllion)
4 Others Market, By Region, 2020-2028 (USD Mllion)
5 Global Antibody Discovery Market, By End User, 2020-2028 (USD Mllion)
6 Pharmaceutical and Biotechnology Industry Market, By Region, 2020-2028 (USD Mllion)
7 Research Laboratory Market, By Region, 2020-2028 (USD Mllion)
8 Academic Laboratory Market, By Region, 2020-2028 (USD Mllion)
9 Global Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Mllion)
10 Humanized Antibody Market, By Region, 2020-2028 (USD Mllion)
11 Human Antibody Market, By Region, 2020-2028 (USD Mllion)
12 Chimeric Antibody Market, By Region, 2020-2028 (USD Mllion)
13 Murine Antibody Market, By Region, 2020-2028 (USD Mllion)
14 Regional Analysis, 2020-2028 (USD Mllion)
15 North America Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
16 North America Antibody Discovery Market, By End User, 2020-2028 (USD Million)
17 North America Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
18 North America Antibody Discovery Market, By Country, 2020-2028 (USD Million)
19 U.S Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
20 U.S Antibody Discovery Market, By End User, 2020-2028 (USD Million)
21 U.S Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
22 Canada Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
23 Canada Antibody Discovery Market, By End User, 2020-2028 (USD Million)
24 Canada Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
25 Mexico Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
26 Mexico Antibody Discovery Market, By End User, 2020-2028 (USD Million)
27 Mexico Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
28 Europe Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
29 Europe Antibody Discovery Market, By End User, 2020-2028 (USD Million)
30 Europe Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
31 Europe Antibody Discovery Market, By Country, 2020-2028 (USD Million)
32 Germany Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
33 Germany Antibody Discovery Market, By End User, 2020-2028 (USD Million)
34 Germany Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
35 U.K Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
36 U.K Antibody Discovery Market, By End User, 2020-2028 (USD Million)
37 U.K Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
38 France Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
39 France Antibody Discovery Market, By End User, 2020-2028 (USD Million)
40 France Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
41 Italy Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
42 Italy Antibody Discovery Market, By End Use , 2020-2028 (USD Million)
43 Italy Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
44 Spain Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
45 Spain Antibody Discovery Market, By End User, 2020-2028 (USD Million)
46 Spain Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
47 Netherlands Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
48 Netherlands Antibody Discovery Market, By End User, 2020-2028 (USD Million)
49 Netherlands Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
50 Rest Of Europe Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
51 Rest Of Europe Antibody Discovery Market, By End User, 2020-2028 (USD Million)
52 Rest of Europe Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
53 Asia Pacific Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
54 Asia Pacific Antibody Discovery Market, By End User, 2020-2028 (USD Million)
55 Asia Pacific Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
56 Asia Pacific Antibody Discovery Market, By Country, 2020-2028 (USD Million)
57 China Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
58 China Antibody Discovery Market, By End User, 2020-2028 (USD Million)
59 China Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
60 India Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
61 India Antibody Discovery Market, By End User, 2020-2028 (USD Million)
62 India Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
63 Japan Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
64 Japan Antibody Discovery Market, By End User, 2020-2028 (USD Million)
65 Japan Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
66 South Korea Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
67 South Korea Antibody Discovery Market, By End User, 2020-2028 (USD Million)
68 South Korea Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
69 SingaporeAntibody Discovery Market, By Methods, 2020-2028 (USD Million)
70 Singapore Antibody Discovery Market, By End User, 2020-2028 (USD Million)
71 Singapore Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
72 Malaysia Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
73 Malaysia Antibody Discovery Market, By End User, 2020-2028 (USD Million)
74 Malaysia Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
75 Thailand Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
76 Thailand Antibody Discovery Market, By End User, 2020-2028 (USD Million)
77 Thailand Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
78 Vietnam Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
79 Vietnam Antibody Discovery Market, By End User, 2020-2028 (USD Million)
80 Vietnam Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
81 Taiwan Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
82 Taiwan Antibody Discovery Market, By End User, 2020-2028 (USD Million)
83 Taiwan Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
84 Rest of Asia Pacific Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
85 Rest of Asia Pacific Antibody Discovery Market, By End User, 2020-2028 (USD Million)
86 Rest of Asia PacificAntibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
87 Middle East and Africa Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
88 Middle East and Africa Antibody Discovery Market, By End User, 2020-2028 (USD Million)
89 Middle East and Africa Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
90 Middle East and Africa Antibody Discovery Market, By Country, 2020-2028 (USD Million)
91 Saudi Arabia Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
92 Saudi Arabia Antibody Discovery Market, By End User, 2020-2028 (USD Million)
93 Saudi Arabia Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
94 UAE Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
95 UAE Antibody Discovery Market, By End User, 2020-2028 (USD Million)
96 UAE Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
97 Israel Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
98 Israel Antibody Discovery Market, By End User, 2020-2028 (USD Million)
99 Israel Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
100 South Africa Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
101 South Africa Antibody Discovery Market, By End User, 2020-2028 (USD Million)
102 South Africa Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
103 Rest of Middle East and Africa Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
104 Rest of Middle East and Africa Antibody Discovery Market, By End User, 2020-2028 (USD Million)
105 Rest of Middle East and Africa Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
106 Central and South America Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
107 Central and South America Antibody Discovery Market, By End User, 2020-2028 (USD Million)
108 Central and South America Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
109 Central and South America Antibody Discovery Market, By Country, 2020-2028 (USD Million)
110 Brazil Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
111 Brazil Antibody Discovery Market, By End User, 2020-2028 (USD Million)
112 Brazil Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
113 Argentina Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
114 Argentina Antibody Discovery Market, By End User, 2020-2028 (USD Million)
115 Argentina Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
116 Chile Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
117 Chile Antibody Discovery Market, By End User, 2020-2028 (USD Million)
118 Chile Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
119 Rest of Central and South America Antibody Discovery Market, By Methods, 2020-2028 (USD Million)
120 Rest of Central and South America Antibody Discovery Market, By End User, 2020-2028 (USD Million)
121 Rest of Central and South America Antibody Discovery Market, By Antibody Type, 2020-2028 (USD Million)
122 Biocytogen: Products & Services Offering
123 Twist Bioscience: Products & Services Offering
124 Creative Biolabs: Products & Services Offering
125 Genscript Technology Corporation: Products & Services Offering
126 Eurofins Scientific.: Products & Services Offering
127 SARTORIUS AG: Products & Services Offering
128 Fairjourney Biologics S.A : Products & Services Offering
129 Danaher Corporation: Products & Services Offering
130 Evotec, Inc: Products & Services Offering
131 Charles River Laboratories: Products & Services Offering
132 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Antibody Discovery Market Overview
2 Global Antibody Discovery Market Value From 2020-2028 (USD Mllion)
3 Global Antibody Discovery Market Share, By Methods (2022)
4 Global Antibody Discovery Market Share, By End User (2022)
5 Global Antibody Discovery Market Share, By Antibody Type (2022)
6 Global Antibody Discovery Market, By Region (Asia Pacific Market)
7 Technological Trends In Global Antibody Discovery Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Antibody Discovery Market
11 Impact Of Challenges On The Global Antibody Discovery Market
12 Porter’s Five Forces Analysis
13 Global Antibody Discovery Market: By Methods Scope Key Takeaways
14 Global Antibody Discovery Market, By Methods Segment: Revenue Growth Analysis
15 Phage Display Market, By Region, 2020-2028 (USD Mllion)
16 Hybridoma Market, By Region, 2020-2028 (USD Mllion)
17 Others Market, By Region, 2020-2028 (USD Mllion)
18 Global Antibody Discovery Market: By End User Scope Key Takeaways
19 Global Antibody Discovery Market, By End User Segment: Revenue Growth Analysis
20 Pharmaceutical and Biotechnology Industry Market, By Region, 2020-2028 (USD Mllion)
21 Research Laboratory Market, By Region, 2020-2028 (USD Mllion)
22 Academic Laboratory Market, By Region, 2020-2028 (USD Mllion)
23 Global Antibody Discovery Market: By Antibody Type Scope Key Takeaways
24 Global Antibody Discovery Market, By Antibody Type Segment: Revenue Growth Analysis
25 Humanized Antibody Market, By Region, 2020-2028 (USD Mllion)
26 Human Antibody Market, By Region, 2020-2028 (USD Mllion)
27 Chimeric Antibody Market, By Region, 2020-2028 (USD Mllion)
28 Murine Antibody Market, By Region, 2020-2028 (USD Mllion)
29 Regional Segment: Revenue Growth Analysis
30 Global Antibody Discovery Market: Regional Analysis
31 North America Antibody Discovery Market Overview
32 North America Antibody Discovery Market, By Methods
33 North America Antibody Discovery Market, By End User
34 North America Antibody Discovery Market, By Antibody Type
35 North America Antibody Discovery Market, By Country
36 U.S. Antibody Discovery Market, By Methods
37 U.S. Antibody Discovery Market, By End User
38 U.S. Antibody Discovery Market, By Antibody Type
39 Canada Antibody Discovery Market, By Methods
40 Canada Antibody Discovery Market, By End User
41 Canada Antibody Discovery Market, By Antibody Type
42 Mexico Antibody Discovery Market, By Methods
43 Mexico Antibody Discovery Market, By End User
44 Mexico Antibody Discovery Market, By Antibody Type
45 Four Quadrant Positioning Matrix
46 Company Market Share Analysis
47 Biocytogen: Company Snapshot
48 Biocytogen: SWOT Analysis
49 Biocytogen: Geographic Presence
50 Twist Bioscience: Company Snapshot
51 Twist Bioscience: SWOT Analysis
52 Twist Bioscience: Geographic Presence
53 Creative Biolabs: Company Snapshot
54 Creative Biolabs: SWOT Analysis
55 Creative Biolabs: Geographic Presence
56 Genscript Technology Corporation: Company Snapshot
57 Genscript Technology Corporation: Swot Analysis
58 Genscript Technology Corporation: Geographic Presence
59 Eurofins Scientific.: Company Snapshot
60 Eurofins Scientific.: SWOT Analysis
61 Eurofins Scientific.: Geographic Presence
62 Sartorius AG: Company Snapshot
63 Sartorius AG: SWOT Analysis
64 Sartorius AG: Geographic Presence
65 Fairjourney Biologics S.A : Company Snapshot
66 Fairjourney Biologics S.A : SWOT Analysis
67 Fairjourney Biologics S.A : Geographic Presence
68 Danaher Corporation: Company Snapshot
69 Danaher Corporation: SWOT Analysis
70 Danaher Corporation: Geographic Presence
71 Evotec, Inc.: Company Snapshot
72 Evotec, Inc.: SWOT Analysis
73 Evotec, Inc.: Geographic Presence
74 Charles River Laboratories: Company Snapshot
75 Charles River Laboratories: SWOT Analysis
76 Charles River Laboratories: Geographic Presence
77 Other Companies: Company Snapshot
78 Other Companies: SWOT Analysis
79 Other Companies: Geographic Presence
The Global Antibody Discovery Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Antibody Discovery Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
